hotspot -WSS

hotspot

author：fashion 2025-09-03 03:25:49 - browse：92658

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： The high cost of giving birth even with insurance
Next article： Option Care buys Amedisys in $3.6 billion home care deal

WSS

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Grail is spending more than ever lobbying Congress

Option Care buys Amedisys in $3.6 billion home care deal

UnitedHealth’s board chair also owns a personal investment firm

STAT Summit: GSK CEO on pharma giant's new direction

These geoengineering technologies could help combat the climate crisis, scientists say

entertainment

hotspot

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

FDA warns J&J's Abiomed: We will regulate your software

After affirmative action ruling, medical educators look to 'holistic review'

A new study asks: Are we harming blood donors by taking blood?

How one medical school became remarkably diverse

Australia's humpback populations rebound raising hopes of marine scientists

Trump demands the U.S. pay no more for drugs than other countries … again

7 people shot in DC, police say

Hollywood unions extend contract negotiations for actors

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

focus

New case study details death in closely watched Alzhiemer's trial

RaDonda Vaught case: a double standard for nurses, physicians

Senate committee scrutinizes Medicare Advantage brokers

Pharmacists can make shortage drugs, but at what cost?

FDA gives detailed accounting of AI

CEOs share strategies for surviving biotech slump

leisure time

hotspot

focus

explore